Does the CYP1B1 rs1056836 GG genotype shift estradiol metabolism toward genotoxic 4-hydroxylation?

The CYP1B1 rs1056836 GG genotype (encoding the Leu432 variant) is a significant genetic determinant of estrogen metabolism, specifically influencing the shift toward potentially genotoxic pathways in estrogen-sensitive tissues.

Clinical and Enzymatic Evidence

Genetic and biochemical analyses confirm that the rs1056836 polymorphism alters the catalytic efficiency and throughput of the CYP1B1 enzyme.

• Enzymatic Activity: The GG genotype (Leu/Leu) is associated with higher functional enzyme activity and increased metabolic throughput compared to the CC (Val/Val) genotype. In vitro kinetic studies show that this variant exhibits high catalytic efficiency ($k_{cat}/K_m$ ~53 mL/(min·mol CYP)), particularly for estrogenic and certain xenobiotic substrates.
• Metabolic Profile: Women carrying the G allele demonstrate significantly higher levels of urinary estrogen metabolites. This indicates an accelerated breakdown of parent estrogens (like 17β-estradiol) into downstream hydroxy-derivatives.

Mechanistic Pathways

The primary concern with elevated CYP1B1 activity is its high regioselectivity for the 4-hydroxylation of estradiol, a pathway distinct from the more benign 2-hydroxylation performed by CYP1A1.

• Catechol Estrogen Formation: Increased activity favors the production of 4-hydroxyestradiol (4-OHE2). Structural modeling confirms that the active site of the CYP1B1 enzyme facilitates a specific orientation of the estradiol molecule that prioritizes attack at the 4-position.
• Reactive Metabolites: 4-OHE2 is a reactive catechol estrogen that can be further oxidized into estrogen-3,4-quinones. These quinones are highly unstable and form depurinating DNA adducts (such as N6Ade-4-OHE2 and N7Gua-4-OHE2), which are established drivers of mutagenesis and tumor initiation.
• Oxidative and Proliferative Signaling: The redox cycling between 4-OHE2 and its quinone forms generates reactive oxygen species (ROS), including superoxide and hydroxyl radicals. This oxidative stress activates redox-sensitive proliferative pathways, such as PI3K/AKT and NF-κB, which promote cellular survival and uncontrolled growth in tissues like the breast and endometrium.

Bottom line

The CYP1B1 rs1056836 GG genotype is strongly linked to increased enzyme activity that favors the production of 4-hydroxyestradiol. This metabolic shift increases the risk of DNA damage and oxidative stress through the formation of reactive quinones and ROS, providing a clear mechanistic link to enhanced proliferative signaling in estrogen-sensitive tissues.